Policy WatchMay 13, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal...
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafety Why This Matters I don't see an article...
Cannabis Products and Contaminant Detection: Critical Review of Regulatory Oversight and Analytical Methodologies.
A comprehensive review of cannabis contaminant testing regulatory inconsistencies reveals significant gaps in safety oversight across U.S. jurisdictions. This analysis highlights critical patient safety concerns stemming from variable testing standards for heavy metals, pesticides, and other contaminants. The findings underscore the urgent need for standardized cannabis safety protocols to protect medical and adult-use consumers.
CED Regulatory Digest, Since Last Digest, 1 items
Digest covering 1 recent regulatory items.
IIPR and Cannabis Reform: 280E Relief and Schedule III Upside – April 16, 2026
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchSchedule IiiMedical AccessRegulation Why This MattersSchedule III reclassification would fundamentally alter the regulatory environment...
Wildings in Newport, Wales: the grand department store that became an illicit cannabis farm
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyRegulationQuality ControlPatient SafetyIllicit Market Why This MattersLarge-scale illicit cannabis operations represent unregulated production...
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic European PolicyMarket DevelopmentProduct StandardsRegulationClinical Access Why This MattersEuropean cannabis market consolidation signals potential standardization...
More than 350 cannabis plants seized from Kalgoorlie home – ABC News
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyLegal AccessPatient SafetyRegulationAustralia Why This MattersLaw enforcement actions like this highlight the ongoing disconnect...
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdRespiratoryEvidence-Based MedicinePatient SafetyRegulation Why This MattersPatients frequently ask about CBD for respiratory conditions, but...
Dog CBD Anxiety Gummies: What Pet Owners Need to Know Before Trying Them
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic VeterinaryAnxietyCbdSafetyRegulation Why This MattersPet owners increasingly seek CBD products for animal anxiety, but veterinary...